Colorado Gov orders preferred Rx drug list

19 February 2007

The US state of Colorado's Governor, Bill Ritter (Democrat), has signed an executive order to prepare for the creation of a preferred prescription drug list as the prelude to enrollment in a multistate purchasing pool for local Medicaid programs. The measure could save $1.6 million annually, based on Colorado's Medicare prescription drugs bill for the current year of $96.0 million.

The procedure drew some criticism from Republican party opponents in the state legislature, who noted that the order avoids the option of a public debate on the subject. Former Governor Bill Owens (Republican) vetoed similar proposals twice, citing objections from patient groups representing mental health conditions, who were concerned about the lack of choice that might ensue from a state formulary.

Gov Ritter told the Denver Post newspaper that previous debates had adequately allowed all views to be aired. The endorsement of the prescription drug purchasing pool by both the local division of the American Association for Retired People and the National Alliance for the Mentally Ill (which opposed previous proposals) marks a turnaround for the plan's chances of becoming reality.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight